24-h systolic blood pressure variability

Biomarker1 paper4 findings

A human study associates 24-hour systolic blood pressure variability with greater left ventricular mass index, left ventricular hypertrophy, target-organ damage and microalbuminuria in untreated white-coat hypertension.

  • Humans1

Associations

4

Microalbuminuria

upin humans1

1 study
  1. 24-h systolic blood pressure variability is associated with microalbuminuria in humans (β=0.105, 95% CI 0.052-0.157).

    Humansuntreated white-coat hypertension

    Short-Term 24-h Systolic Blood Pressure Variability and Subclinical Target-Organ Damage in White-Coat Hypertension: A Retrospective Cross-Sectional Study · Vascular health and risk management · 16 Sep 2026

Microalbuminuria →

Left ventricular mass index

upin humans1

1 study
  1. 24-h systolic blood pressure variability is associated with left ventricular mass index in humans (β=2.23 g/m2, 95% CI 0.33-4.12).

    Humansuntreated white-coat hypertension

    Short-Term 24-h Systolic Blood Pressure Variability and Subclinical Target-Organ Damage in White-Coat Hypertension: A Retrospective Cross-Sectional Study · Vascular health and risk management · 16 Sep 2026

Left ventricular mass index →

Left ventricular hypertrophy

upin humans1OR 1.3

1 study
  1. 24-h systolic blood pressure variability is associated with left ventricular hypertrophy in humans (OR 1.30, 95% CI 1.08-1.60).

    Humansuntreated white-coat hypertension

    Short-Term 24-h Systolic Blood Pressure Variability and Subclinical Target-Organ Damage in White-Coat Hypertension: A Retrospective Cross-Sectional Study · Vascular health and risk management · 16 Sep 2026

Left ventricular hypertrophy →

Target-organ damage

upin humans1OR 1.25

1 study
  1. 24-h systolic blood pressure variability is associated with target-organ damage in humans (OR 1.25, 95% CI 1.05-1.52).

    Humansuntreated white-coat hypertension

    Short-Term 24-h Systolic Blood Pressure Variability and Subclinical Target-Organ Damage in White-Coat Hypertension: A Retrospective Cross-Sectional Study · Vascular health and risk management · 16 Sep 2026

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 1Oct 2026: 01